Beyond the surface: analyzing etomidate and propofol as anesthetic agents in electroconvulsive therapy—A systematic review and meta-analysis of seizure duration outcomes

Frontiers in Neurology

Neurology

Syed H. A. Rizvi¹  Sandesh Raja¹  Syed Z. Saleem¹  Syed M. M. Akhtar¹  Muhammad Sohaib Asghar² 

[1] Department of Medicine, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan;Mayo Clinic, Rochester, MN, United States;

关键词: electroconvulsive therapy;    etomidate;    propofol;    seizure duration;    meta-analysis;   

DOI  :  10.3389/fneur.2023.1251882

 received in 2023-07-02, accepted in 2023-09-13,  发布年份 2023

来源: Frontiers

【 摘 要 】

BackgroundElectroconvulsive therapy (ECT) is a widely used treatment for severe psychiatric disorders such as schizophrenia, depression, and mania. The procedure involves applying brief electrical stimulation to induce a seizure, and anesthesia is used to ensure sedation and muscle relaxation. Finding the right anesthetic agent with minimal side effects, especially on seizure duration, is crucial for optimal outcomes because seizure duration is an important factor in the effectiveness of ECT, but the anesthetic agents used can affect it.ObjectiveThis systematic review and meta-analysis aimed to pool the results of all relevant studies comparing the two induction agents, etomidate and propofol, for motor and electroencephalogram (EEG) seizure duration outcomes.MethodsA comprehensive literature search was conducted in the PubMed, Medline, and Cochrane Library databases to identify the relevant articles. The primary outcome measures were motor and EEG seizure durations. Statistical power was ensured by performing heterogeneity, publication bias, sensitivity analysis, and subgroup analysis. Standard mean difference and 95% confidence intervals were calculated for continuous outcomes, and a random-effects model was used.ResultsA total of 16 studies were included in this meta-analysis, comprising 7 randomized control trials (RCTs), 7 crossover trials, and 2 cohorts. The overall motor seizure duration was statistically significantly longer with etomidate than with propofol. The overall result for EEG seizure duration was also longer with the use of etomidate over propofol and was statistically significant. In addition, subgrouping was performed based on the study design for both outcomes, which showed insignificant results in the cohort's subgroup for both outcomes, while the RCTs and crossover subgroups supported the overall results. Heterogeneity was assessed through subgrouping and sensitivity analysis.ConclusionOur meta-analysis found that etomidate is superior to propofol in terms of motor and EEG seizure duration in ECT, implying potentially better efficacy. Hence, etomidate should be considered the preferred induction agent in ECT, but larger studies are needed to further validate our findings.

【 授权许可】

Unknown   
Copyright © 2023 Akhtar, Saleem, Rizvi, Raja and Asghar.